Form S-1/A Polaryx Therapeutics,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260127/AL22WQ2CL222BZ9Z28292ZY2OPPQW222Z282
Filed on: January 27, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nuburu launches $38M public offering at 5% premium to fund Tekne deal
- Sui Group names Ripple Labs ex-CFO Kristina Campbell to its board
- Gloo prices public offering of 7 million shares at $3.25 each
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
